Showing 1 - 2 results of 2 for search 'Kei Fukuhara', query time: 0.01s
Refine Results
-
1
-
2
Japanese Phase 1 Study for Global Development of Anti‐TL1A Antibody PF‐06480605: A Randomized, Placebo‐Controlled, Single‐Ascending Dose Study by Kei Fukuhara, Srividya Neelakantan, Kenichi Furihata, Hirotoshi Yuasa, Nanzhi Shi, Yuichi Yamamoto, Kenneth E. Hung
Published 2025-03-01Get full text
Article